CCM Investment Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Sell
149,542
-3,198
-2% -$369K 1.72% 19
2025
Q4
$16.1M Sell
152,740
-4,031
-3% -$378K 1.54% 28
2025
Q3
$13.2M Sell
156,771
-10,337
-6% -$851K 1.3% 39
2025
Q2
$13.2M Buy
167,108
+22,535
+16% +$1.79M 1.42% 35
2025
Q1
$13M Buy
144,573
+5,746
+4% +$536K 1.59% 37
2024
Q4
$13.8M Buy
138,827
+14,093
+11% +$1.45M 1.53% 29
2024
Q3
$14.2M Sell
124,734
-1,841
-1% -$219K 1.58% 33
2024
Q2
$15.7M Sell
126,575
-452
-0.4% -$58.2K 1.84% 19
2024
Q1
$16.8M Sell
127,027
-8,905
-7% -$1.1M 2% 17
2023
Q4
$14.8M Buy
135,932
+2,235
+2% +$232K 1.82% 22
2023
Q3
$13.8M Buy
133,697
+476
+0.4% +$51.3K 1.9% 20
2023
Q2
$15.4M Sell
133,221
-146
-0.1% -$16.6K 2.06% 13
2023
Q1
$14.2M Buy
133,367
+5,095
+4% +$550K 2.01% 17
2022
Q4
$14.2M Sell
128,272
-15,464
-11% -$1.58M 2.26% 10
2022
Q3
$12.4M Sell
143,736
-2,141
-1% -$191K 2.11% 16
2022
Q2
$13.3M Sell
145,877
-1,305
-0.9% -$116K 2.14% 12
2022
Q1
$12.1M Sell
147,182
-11,668
-7% -$920K 1.65% 33
2021
Q4
$12.2M Buy
158,850
+26
+0% +$2.07K 1.48% 43
2021
Q3
$11.9M Buy
158,824
+7,084
+5% +$539K 1.55% 37
2021
Q2
$11.8M Buy
151,740
+3,224
+2% +$240K 1.51% 40
2021
Q1
$10.9M Buy
148,516
+4,629
+3% +$341K 1.48% 43
2020
Q4
$11.2M Buy
143,887
+821
+0.6% +$62.8K 1.63% 31
2020
Q3
$11.3M Sell
143,066
-2,286
-2% -$179K 1.84% 24
2020
Q2
$10.7M Buy
145,352
+367
+0.3% +$27.6K 1.83% 23
2020
Q1
$10.6M Sell
144,985
-11,988
-8% -$942K 2.13% 12
2019
Q4
$13.6M Sell
156,973
-2,607
-2% -$214K 2.12% 15
2019
Q3
$12.8M Sell
159,580
-6,796
-4% -$545K 2.1% 16
2019
Q2
$13.3M Sell
166,376
-10,134
-6% -$776K 2.24% 12
2019
Q1
$14M Buy
176,510
+347
+0.2% +$26K 2.35% 9
2018
Q4
$12.8M Buy
176,163
+23,761
+16% +$1.68M 2.56% 9
2018
Q3
$10.3M Buy
152,402
+52,441
+52% +$3.34M 1.9% 22
2018
Q2
$5.79M Buy
99,961
+87,951
+732% +$4.96M 1.1% 44
2018
Q1
$624K Sell
12,010
-2,785
-19% -$150K 0.12% 62
2017
Q4
$794K Sell
14,795
-1,643
-10% -$91.1K 0.15% 62
2017
Q3
$1M Sell
16,438
-3,128
-16% -$190K 0.19% 58
2017
Q2
$1.2M Sell
19,566
-12,351
-39% -$752K 0.23% 57
2017
Q1
$1.94M Sell
31,917
-4,276
-12% -$259K 0.39% 58
2016
Q4
$2.03M Sell
36,193
-2,400
-6% -$140K 0.43% 57
2016
Q3
$2.3M Sell
38,593
-3,594
-9% -$210K 0.49% 55
2016
Q2
$2.32M Sell
42,187
-37,984
-47% -$2.02M 0.22% 72
2016
Q1
$4.05M Sell
80,171
-336,664
-81% -$16.5M 0.38% 57
2015
Q4
$21M Buy
416,835
+15,284
+4% +$771K 1.97% 30
2015
Q3
$18.9M Buy
401,551
+22,245
+6% +$1.18M 1.88% 23
2015
Q2
$20.6M Buy
379,306
+46,440
+14% +$2.6M 1.9% 25
2015
Q1
$18.3M Sell
332,866
-59,044
-15% -$3.34M 1.78% 28
2014
Q4
$21.2M Buy
391,910
+11,096
+3% +$618K 1.93% 20
2014
Q3
$21.5M Buy
380,814
+2,639
+0.7% +$148K 1.92% 23
2014
Q2
$20.9M Sell
378,175
-47,029
-11% -$2.57M 1.91% 23
2014
Q1
$23M Sell
425,204
-10,585
-2% -$548K 2.28% 7
2013
Q4
$20.8M Buy
435,789
+10,919
+3% +$499K 1.95% 19
2013
Q3
$19.3M Buy
424,870
+14,060
+3% +$642K 1.92% 17
2013
Q2
$18.2M Buy
+410,810
New +$18.3M 1.87% 14

Other funds holding MRK

CCM Investment Advisers's MRK Position: Q1 2026 in Review

CCM Investment Advisers reduced its Merck (MRK) stake by 2.1% in Q1 2026, selling an estimated $369K and leaving 149,542 shares worth $18M. The position accounts for 1.72% of the portfolio, ranked #19.

CCM Investment Advisers first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $23M in Q1 2014. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • CCM Investment Advisers held 149,542 shares of Merck worth $18M as of Q1 2026.
  • CCM Investment Advisers sold 3,198 Merck shares in Q1 2026, an estimated $369K.
  • Merck made up 1.72% of CCM Investment Advisers's portfolio in Q1 2026, its #19 holding.
  • CCM Investment Advisers first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • CCM Investment Advisers's Merck position peaked at $23M in Q1 2014.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on CCM Investment Advisers's 13F filing for Q1 2026, filed 20 May 2026.